Letters, Testimony & Comments

BIO submits letters, testimony, and comments to government and regulatory bodies throughout the United States and around the world.

Featured Letters, Testimony, & Comments
Comments of the Biotechnology Innovation…
On behalf of its member organizations, Biotechnology Innovation Organization (“BIO”) respectfully submits this Comment in response to the United States Patent and Trademark Office’s (the “Patent Office” or “PTO”) February 13, 2024 Request for…
BIO Comments to FWS on Use of GMOs on National…
BIO comments on a proposed rule to restrict planting of GE organisms on national wildlife refuge lands. 
BIO Comments to the Minnesota Department of…
BIO submits comments on the MDH’s proposed regulations regarding Drugs of Substantial Public Interest: Draft Methodology for Public Comment as required in statute by the Prescription Drug Price Transparency Act.    
All Letters, Testimony & Comments
  • Show All
Search
Results
February 25, 2021
The Biotechnology Innovation Organization is pleased to submit a statement for the record to the United States House of Representatives Committee on Agriculture hearing entitled, "Climate Change and the U.S. Agriculture and Forestry Sectors." BIO…
February 21, 2021
On behalf of the Biotechnology Innovation Organization (BIO) – the world’s largest trade group for the biotechnology sector – I write to express support for Senate File 944, a bill you recently filed that would increase the minimum biofuel content…
February 9, 2021
The Biotechnology Innovation Organization is pleased to submit a statement for the record to the United States House of Representatives Committee on Energy and Commerce Subcommittee on Environment and Climate Change hearing entitled, "Back in Action…
February 5, 2021
We encourage you to formally withdraw the proposed rule from the previous administration to remove IER, and to fully implement IER for the first time.  The International Entrepreneur Rule would allow world-class foreign entrepreneurs to launch…
January 28, 2021
Section 182 of the Trade Act of 1974, known as the “Special 301” provisions, requires the United States Trade Representative to identify countries that deny adequate and effective intellectual property protections or fair and equitable market access…
January 26, 2021
The undersigned food and agriculture trade associations respectfully urge confirmation of Katherine Tai to be U.S. Trade Representative. Our associations represent the vast majority of the food and agriculture sector accounting for roughly one…
January 25, 2021
On behalf of the Biotechnology Innovation Organization (BIO), the nearly 1000 companies, universities, and biotech organizations we represent comprised of millions of scientists, researchers and entrepreneurs, congratulations on your historic…
December 23, 2020
On Wednesday, December 23rd, BIO submitted comments on the U.S. Food and Drug Administration (FDA)’s October 2020 public workshop titled, “New Drugs Regulatory Program Modernization: Implementation of the Integrated Assessment of Marketing…
December 9, 2020
The Biotechnology Innovation Organization (BIO) submits these comments in response to the U.S. Environmental Protection Agency’s (EPA) request for public input on proposed revisions to regulations related to the oversight of certain plant…
December 3, 2020
Innovative breakthroughs can secure our nation’s food supply by reducing greenhouse gas emissions throughout agricultural supply chains; strengthening producers’ resiliency to climate change while increasing production; and tackling hunger and…